Terms: = Lymphoma AND FOXL2, BPES, 668, ENSG00000183770, P58012, PFRK, POF3, PINTO, BPES1 AND Prognosis
9 results:
1. Long term outcomes in older patients with primary central nervous system lymphoma: an analysis of the Texas Cancer Registry.
Burns EA; Sanchez CG; Mathur S; Guerrero C; Muhsen IN; Sarfraz H; Hu CA; Tang CA; Shah SS; Tremont IW; Teh B; Ganguly S; Pingali SRK
Ann Hematol; 2023 May; 102(5):1111-1120. PubMed ID: 36922432
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic value of
Lu RQ; Wu LX; Zhang J; Qin YZ; Liu YR; Lai YY; Jiang H; Chang YJ; Ruan GR; Huang XJ
Hematology; 2021 Dec; 26(1):9-15. PubMed ID: 33357137
[TBL] [Abstract] [Full Text] [Related]
3. [Prognostic evaluation of P53 and BCL2 proteins in MYC/BCL2 double expression DLBCL].
Huang P; Chen S; Yang X; Lei YY; Xu XY; Liu YX; Guo YH; Pan Y; Wang XH; Zhang HL; Fu K; Meng B
Zhonghua Xue Ye Xue Za Zhi; 2019 Jul; 40(7):589-593. PubMed ID: 32397023
[No Abstract] [Full Text] [Related]
4. Serum free light chain response after 2 courses of induction chemotherapy predicts prognosis in myeloma patients.
Yağcı M; Karakaya F; Suyanı E; Haznedar R
Clin Lymphoma Myeloma Leuk; 2015 Feb; 15(2):98-102. PubMed ID: 25441109
[TBL] [Abstract] [Full Text] [Related]
5. Treatment of relapsed or refractory aggressive non-hodgkin lymphoma with two ifosfamide-based regimens, IMVP and ICE.
Aurer I; Mitrović Z; Nemet D; Radman I; Sertić D; Serventi-Seiwerth R; Stern-Padovan R; Santek F; Nola M; Mrsić M; Labar B
J Chemother; 2008 Oct; 20(5):640-4. PubMed ID: 19048695
[TBL] [Abstract] [Full Text] [Related]
6. Plasma cytokine and soluble receptor signature predicts outcome of patients with classical Hodgkin's lymphoma: a study from the Groupe d'Etude des Lymphomes de l'Adulte.
Casasnovas RO; Mounier N; Brice P; Divine M; Morschhauser F; Gabarre J; Blay JY; Voillat L; Lederlin P; Stamatoullas A; Bienvenu J; Guiguet M; Intrator L; Grandjean M; Brière J; Ferme C; Salles G;
J Clin Oncol; 2007 May; 25(13):1732-40. PubMed ID: 17389336
[TBL] [Abstract] [Full Text] [Related]
7. [Novel approaches to combination therapy of Hodgkin's disease].
Kharchenko VP; Pan'shin GA; Datsenko PV; Sotnikov VM; Mel'nik IuD
Vopr Onkol; 2005; 51(6):692-6. PubMed ID: 17037037
[TBL] [Abstract] [Full Text] [Related]
8. Superior 12-year survival after at least 4-year continuous remission with tandem transplantations for multiple myeloma.
Barlogie B; Zangari M; Bolejack V; Hollmig K; Anaissie E; van Rhee F; Pineda-Roman M; Mohiuddin A; Crowley J; Tricot G
Clin Lymphoma Myeloma; 2006 May; 6(6):469-74. PubMed ID: 16796777
[TBL] [Abstract] [Full Text] [Related]
9. Soluble intercellular adhesion molecule-1 (s-ICAM-1/s-CD54) in diffuse large B-cell lymphoma: association with clinical characteristics and outcome.
Terol MJ; Tormo M; Martinez-Climent JA; Marugan I; Benet I; Ferrandez A; Teruel A; Ferrer R; García-Conde J
Ann Oncol; 2003 Mar; 14(3):467-74. PubMed ID: 12598355
[TBL] [Abstract] [Full Text] [Related]
